Vicinitas Therapeutics

Vicinitas Therapeutics is a biotech company in South San Francisco, United States, founded in 2022. It has raised $65.0M across 1 round, most recently a $65.0M Series A in July 2022.

Employees
11–50
Founded
2022
Business Model
B2B
Total Funding
$65.0M
Last Round
$65.0M Series AJul 2022
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 6 investors for this company. The full record is or through the API.

About

Vicinitas Therapeutics is a biotechnology company developing precision medicines based on targeted protein stabilization. Its proprietary platform uses Deubiquitinase Targeting Chimeras (DUBTACs) — small molecules that rescue proteins erroneously tagged for degradation by the cell's ubiquitin-proteasome system, restoring healthy protein levels rather than destroying disease-causing proteins as most targeted-protein-degradation approaches do. The science was pioneered in Daniel Nomura's laboratory at UC Berkeley. Vicinitas targets diseases driven by the loss of functional proteins, including cancers and genetic disorders such as cystic fibrosis. The company launched in July 2022 with a $65 million Series A financing co-led by Andreessen Horowitz (a16z) and Deerfield Management, with participation from Droia Ventures and the Berkeley Catalyst Fund. It is based in the San Francisco Bay Area.

Summary

It lists 11–50 employees. It has raised $65.0M in total across 1 round, most recently a $65.0M Series A round in Jul 2022. Investors include Andreessen Horowitz, Deerfield Management and Droia Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries AJul 2022
$65.0M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Vicinitas Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/vicinitas-therapeutics"><img src="https://indexed.vc/api/badge/company/vicinitas-therapeutics" alt="Vicinitas Therapeutics on Indexed.vc" width="260" height="76" /></a>